Overview
What It Is Transcutaneous auricular vagus-nerve stimulation delivers mild electrical pulses to the auricular branch of the vagus nerve via an ear electrode or wearable device. Because it is non-invasive, it can be used at home or in clinic on a regular schedule for mood, seizure adjunct, inflammation, and other research targets.
How It Works Stimulating vagal afferents influences brainstem nuclei that regulate autonomic state, inflammation, and limbic activity. Repeated sessions may support more flexible autonomic regulation and, in some applications, reduce seizure likelihood or improve mood—neuromodulation of pathways that gate plasticity and arousal.
Conditions - Emerging-to-moderate evidence for: depression symptoms and adjunctive use in drug-resistant epilepsy. - Also researched for: pain, inflammation, and cognitive applications. - Note: Local skin irritation is the most common side effect. Devices range from research tools to consumer/clinical wearables.
How it is administered
At-home or clinic use of an ear electrode or wearable device that delivers mild electrical pulses. Sessions follow a prescribed schedule and parameters set for the target condition.
Conditions connected in the NPA database
The NPA Treatment Database lists this treatment in connection with 7 condition records. A database relationship does not establish effectiveness, safety, or suitability for an individual.
Related questions
These controlled question pages reference this treatment through stored condition relationships.
- What treatments are listed for Anxiety Disorders in the NPA database?
- What treatments are listed for Clinical Depression in the NPA database?
- What treatments are listed for Epilepsy in the NPA database?
- What treatments are listed for Migraine & Headaches in the NPA database?
- What treatments are listed for Persistent Pain in the NPA database?
- What treatments are listed for Stroke in the NPA database?
- What treatments are listed for Traumatic Brain Injury (TBI) in the NPA database?
Symptoms connected in the NPA database
The current record associates this treatment with the following symptom information. This is not a claim that the treatment will improve these symptoms.
Cognition & Memory
- concentration issues
- Confusion or memory gaps after seizures
- Difficulty concentrating
- Difficulty concentrating (“brain fog”)
- indecisiveness
- memory complaints
- mental fog
- mental fog during/after attacks
- racing thoughts
- Short-term memory issues
- Short-term memory problems
- slowed processing
- slowed thinking
- spatial neglect
- worry
Emotion & Behavior
- anxiety
- anxiety around seizures
- avoidance behaviors
- depression
- emotional lability (uncontrollable laughing/crying)
- Excessive fear or worry
- Fear or déjà vu auras
- feelings of worthlessness
- frustration
- impulsivity
- irritability
- loss of interest/pleasure
- mood changes
- mood changes before or during attacks
- mood swings
- Persistent sadness
- social withdrawal
Motor Control
- Balance and coordination problems
- difficulty walking
- guarding
- loss of muscle control
- muscle stiffness/spasticity
- muscle tension
- Occasional weakness or coordination changes during aura (rare subtypes)
- One-sided weakness or paralysis
- poor balance and coordination
- post-seizure weakness
- reduced fine motor skills
- Reduced mobility
- Restlessness
- Seizure-related jerking
- slowed movements
- Slowed movements or restlessness (psychomotor changes)
- stiffening
- trembling
- weakness
Sensory & Pain
- central post-stroke pain (burning, shooting pain, and sensitivity to touch, temperature)
- headaches
- heightened sensitivity
- muscle aches
- nausea
- Numbness or altered sensation
- numbness or tingling
- Persistent headaches
- Persistent pain (aching, burning, stabbing)
- Physical sensations (heart racing, chest tightness, sweating)
- sensitivity to light/noise
- sensitivity to light/sound/smell
- Sensory auras (tingling, unusual sensations)
- Throbbing or pulsing head pain
- tinnitus
- Unexplained aches and pains
Sleep & Fatigue
- Excessive fatigue
- fatigue
- Insomnia or excessive sleepiness
- Insomnia or hypersomnia
- post-attack exhaustion
- Post-ictal fatigue
- profound fatigue and low energy
- profound physical and mental fatigue
- sleep disruption
- Sleep disruption due to pain
- sleep disruption from nocturnal seizures
- sleep disturbances
- Trouble falling or staying asleep
Practical information
Insurance coverage
Limited; coverage rare outside specific research or approved uses.
Cost information
Devices $200–$1,000+; varies.
Results and outcomes described in the source record
Effects on mood or other symptoms often assessed over weeks.
Side effects and risks
Generally well-tolerated. Possible local skin irritation or mild discomfort.
Research context in the NPA database
This section reproduces the current database's research summary and detail. Structured citation metadata has not been supplied, so it should not be read as an independently verified literature review.
Research summary
Evidence Level: Emerging to Moderate
What the research shows: Studies support non-invasive ear-based vagus nerve stimulation for mood symptoms and as an adjunct for seizure reduction. Research is still growing across other applications.
Key takeaway: A non-surgical vagus-nerve approach that can be used at home or in clinic under guidance.
Research detail
Overview Transcutaneous auricular vagus-nerve stimulation delivers mild electrical pulses to the auricular branch of the vagus nerve via an ear electrode or wearable device. Because the stimulation is non-invasive, it can be performed at home or in clinic on a regular schedule. Research and clinical use have explored taVNS for depression, anxiety, epilepsy (as an adjunct for seizure reduction), inflammation, and some cognitive or pain applications. Parameters such as frequency, intensity, and duration are adjusted according to the target condition.
Evidence Base and Published Work • Clinical trials support non-invasive ear-based vagus-nerve stimulation for mood symptoms and as an adjunct for seizure reduction in drug-resistant epilepsy. • Systematic reviews of taVNS for depression, epilepsy, and neuromodulation applications document emerging-to-moderate evidence. • Key published work includes: – Clinical trials for depression and adjunctive seizure reduction. – Systematic reviews of taVNS for depression, epilepsy, and neuromodulation applications. – Local skin irritation is the most common side effect; systemic risks are low. Devices can be used at home or in clinic. Research continues to expand across other indications.
Outcomes Outcomes most frequently described include benefits for mood symptoms and adjunctive seizure reduction. Evidence is emerging to moderate.
Questions to ask a provider
1. Is non-invasive ear-based vagus nerve stimulation appropriate for my mood, seizure, or other symptoms? 2. What device and stimulation parameters do you recommend, and how often should I use it? 3. What evidence exists for taVNS for my specific condition, and what results are realistic? 4. What side effects (skin irritation, etc.) should I watch for? 5. Is a prescription device required, and is any portion covered by insurance?
Explore the interactive Treatment Database
Continue to compare educational treatment information in the interactive database. The standard disclaimer acknowledgement is required before the database opens.
Explore treatment information in the database